Wauquier, F., Chavanelle, V., Bouchard-Mercier, A., Boutin-Wittrant, L., Otero, Y. F., Krisa, S., Valls, J., Joubioux, F. L., Pereira, B., Roux, V., Macian, N., Pickering, G., Sapone, V., Cazaubiel, M., Bron, A., Peltier, S., Blanquet, S., Sirvent, P., Wittrant, Y. (2025). Bioavailable human metabolites from TOTUM-448 (plant-based formulation) maintain liver cell functionality in a hyperlipidic context that drives MASLD onset. Scientific Reports. https://doi.org/10.1038/s41598-025-32556-z